ID   KC1G3_HUMAN             Reviewed;         447 AA.
AC   Q9Y6M4; Q86WZ7; Q9Y6M3;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   05-OCT-2010, entry version 99.
DE   RecName: Full=Casein kinase I isoform gamma-3;
DE            Short=CKI-gamma 3;
DE            EC=2.7.11.1;
GN   Name=CSNK1G3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   MEDLINE=99126346; PubMed=9925945;
RA   Kusuda J., Hirai M., Toyoda A., Tanuma R., Hashimoto K.;
RT   "Cloning and chromosome mapping of the human casein kinase I gamma3
RT   gene (CSNK1G3).";
RL   Cytogenet. Cell Genet. 83:101-103(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-29; SER-32; THR-256;
RP   SER-344; SER-397; SER-398; THR-399 AND SER-413, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365 AND SER-366 (ISOFORM
RP   3), AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 35-362 IN COMPLEX WITH
RP   INHIBITOR DKI.
RA   Bunkoczi G., Salah E., Rellos P., Das S., Fedorov O., Savitsky P.,
RA   Gileadi O., Sundstrom M., Edwards A., Arrowsmith C., Ugochukwu E.,
RA   Weigelt J., Von Delft F., Knapp S.;
RT   "Structure of casein kinase 1 gamma 3.";
RL   Submitted (MAR-2006) to the PDB data bank.
CC   -!- FUNCTION: Casein kinases are operationally defined by their
CC       preferential utilization of acidic proteins such as caseins as
CC       substrates. It can phosphorylate a large number of proteins.
CC       Participates in Wnt signaling (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Monomer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=3;
CC         IsoId=Q9Y6M4-1; Sequence=Displayed;
CC       Name=2; Synonyms=3L, CSNK1G3L;
CC         IsoId=Q9Y6M4-2; Sequence=VSP_004749;
CC       Name=3;
CC         IsoId=Q9Y6M4-3; Sequence=VSP_010256, VSP_004749;
CC         Note=Phosphorylated on Ser-365 and Ser-366;
CC   -!- PTM: Autophosphorylated (By similarity).
CC   -!- MISCELLANEOUS: Triazolodiamine 1 is a commercial name for 5-amino-
CC       3-([4-(aminosulfonyl)phenyl]amino)-N-(2,6-difluorophenyl)-1H-
CC       1,2,4-triazole-1-carbothioamide.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF049089; AAD26525.1; -; mRNA.
DR   EMBL; AF049090; AAD26526.1; -; mRNA.
DR   EMBL; BC047567; AAH47567.1; -; mRNA.
DR   IPI; IPI00181294; -.
DR   IPI; IPI00218437; -.
DR   IPI; IPI00941996; -.
DR   RefSeq; NP_001026982.1; -.
DR   RefSeq; NP_001038187.1; -.
DR   RefSeq; NP_001038188.1; -.
DR   RefSeq; NP_004375.2; -.
DR   UniGene; Hs.129206; -.
DR   PDB; 2CHL; X-ray; 1.95 A; A=35-362.
DR   PDB; 2IZR; X-ray; 1.30 A; A=35-362.
DR   PDB; 2IZS; X-ray; 1.95 A; A=35-362.
DR   PDB; 2IZT; X-ray; 2.00 A; A=35-362.
DR   PDB; 2IZU; X-ray; 1.85 A; A=35-362.
DR   PDBsum; 2CHL; -.
DR   PDBsum; 2IZR; -.
DR   PDBsum; 2IZS; -.
DR   PDBsum; 2IZT; -.
DR   PDBsum; 2IZU; -.
DR   ProteinModelPortal; Q9Y6M4; -.
DR   STRING; Q9Y6M4; -.
DR   PhosphoSite; Q9Y6M4; -.
DR   PRIDE; Q9Y6M4; -.
DR   Ensembl; ENST00000361991; ENSP00000354942; ENSG00000151292.
DR   Ensembl; ENST00000395411; ENSP00000378806; ENSG00000151292.
DR   GeneID; 1456; -.
DR   KEGG; hsa:1456; -.
DR   UCSC; uc003ktl.1; human.
DR   UCSC; uc003ktm.1; human.
DR   UCSC; uc003ktn.1; human.
DR   CTD; 1456; -.
DR   GeneCards; GC05P122909; -.
DR   HGNC; HGNC:2456; CSNK1G3.
DR   HPA; HPA027010; -.
DR   MIM; 604253; gene.
DR   PharmGKB; PA26956; -.
DR   eggNOG; prNOG06781; -.
DR   HOVERGEN; HBG000176; -.
DR   OMA; NREAHPH; -.
DR   OrthoDB; EOG9CG2TK; -.
DR   PhylomeDB; Q9Y6M4; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; hedgehog_glipathway; Hedgehog signaling events mediated by Gli proteins.
DR   NextBio; 5979; -.
DR   ArrayExpress; Q9Y6M4; -.
DR   Bgee; Q9Y6M4; -.
DR   CleanEx; HS_CSNK1G3; -.
DR   Genevestigator; Q9Y6M4; -.
DR   GermOnline; ENSG00000151292; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0016055; P:Wnt receptor signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR022247; Casein_kinase-1_gamma_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF12605; CK1gamma_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Serine/threonine-protein kinase; Transferase; Wnt signaling pathway.
FT   CHAIN         1    447       Casein kinase I isoform gamma-3.
FT                                /FTId=PRO_0000192846.
FT   DOMAIN       43    313       Protein kinase.
FT   NP_BIND      49     57       ATP (By similarity).
FT   ACT_SITE    162    162       Proton acceptor (By similarity).
FT   BINDING      72     72       ATP (By similarity).
FT   BINDING     117    117       Inhibitor triazolodiamine 1; via carbonyl
FT                                oxygen.
FT   BINDING     119    119       Inhibitor triazolodiamine 1; via amide
FT                                nitrogen and carbonyl oxygen.
FT   MOD_RES      29     29       Phosphothreonine.
FT   MOD_RES      32     32       Phosphoserine.
FT   MOD_RES     256    256       Phosphothreonine.
FT   MOD_RES     344    344       Phosphoserine.
FT   MOD_RES     397    397       Phosphoserine.
FT   MOD_RES     398    398       Phosphoserine.
FT   MOD_RES     399    399       Phosphothreonine.
FT   MOD_RES     413    413       Phosphoserine.
FT   VAR_SEQ     363    394       Missing (in isoform 3).
FT                                /FTId=VSP_010256.
FT   VAR_SEQ     430    430       K -> NCQKVLNMW (in isoform 2 and isoform
FT                                3).
FT                                /FTId=VSP_004749.
FT   CONFLICT     91     91       K -> E (in Ref. 2; AAH47567).
FT   CONFLICT    174    174       G -> R (in Ref. 1; AAD26525/AAD26526).
FT   CONFLICT    302    302       D -> E (in Ref. 1; AAD26525/AAD26526).
FT   TURN         40     42
FT   STRAND       43     48
FT   STRAND       56     62
FT   TURN         63     66
FT   STRAND       67     75
FT   HELIX        83     93
FT   STRAND      102    108
FT   STRAND      111    117
FT   HELIX       123    129
FT   TURN        130    132
FT   HELIX       136    155
FT   HELIX       165    167
FT   STRAND      168    170
FT   HELIX       173    175
FT   STRAND      180    183
FT   STRAND      190    193
FT   TURN        195    197
FT   TURN        213    215
FT   HELIX       218    221
FT   HELIX       228    244
FT   TURN        248    251
FT   HELIX       257    270
FT   HELIX       273    276
FT   TURN        277    279
FT   HELIX       281    292
FT   HELIX       301    314
FT   TURN        324    327
SQ   SEQUENCE   447 AA;  51389 MW;  6FAEDD605579ED3A CRC64;
     MENKKKDKDK SDDRMARPSG RSGHNTRGTG SSSSGVLMVG PNFRVGKKIG CGNFGELRLG
     KNLYTNEYVA IKLEPMKSRA PQLHLEYRFY KQLGSGDGIP QVYYFGPCGK YNAMVLELLG
     PSLEDLFDLC DRTFSLKTVL MIAIQLISRM EYVHSKNLIY RDVKPENFLI GRPGNKTQQV
     IHIIDFGLAK EYIDPETKKH IPYREHKSLT GTARYMSINT HLGKEQSRRD DLEALGHMFM
     YFLRGSLPWQ GLKADTLKER YQKIGDTKRA TPIEVLCENF PEMATYLRYV RRLDFFEKPD
     YDYLRKLFTD LFDRKGYMFD YEYDWIGKQL PTPVGAVQQD PALSSNREAH QHRDKMQQSK
     NQSADHRAAW DSQQANPHHL RAHLAADRHG GSVQVVSSTN GELNTDDPTA GRSNAPITAP
     TEVEVMDETK CCCFFKRRKR KTIQRHK
//
